"Flecainide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
| Descriptor ID |
D005424
|
| MeSH Number(s) |
D03.383.621.270
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Flecainide".
Below are MeSH descriptors whose meaning is more specific than "Flecainide".
This graph shows the total number of publications written about "Flecainide" by people in this website by year, and whether "Flecainide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2010 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flecainide" by people in Profiles.
-
Crijns HJGM, Elvan A, Al-Windy N, Tuininga YS, Badings E, Aksoy I, Van Gelder IC, Madhavapeddi P, Camm AJ, Kowey PR, Ruskin JN, Belardinelli L. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. Circ Arrhythm Electrophysiol. 2022 03; 15(3):e010204.
-
Rodriguez MA, Helms E, Shubert J, Pavri BB. Pacemaker malfunction induced by a pharmaco-metabolic "perfect storm": a brief report. J Clin Pharmacol. 2011 Jan; 51(1):107-9.
-
Lu HR, Rohrbacher J, Vlaminckx E, Van Ammel K, Yan GX, Gallacher DJ. Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers. Br J Pharmacol. 2010 May; 160(1):60-76.
-
Kowey PR, Breithardt G, Camm J, Crijns H, Dorian P, Le Heuzey JY, Pedrazzini L, Prystowsky EN, Salette G, Schwartz PJ, Torp-Pedersen C, Weintraub W. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clin Cardiol. 2010 Mar; 33(3):172-8.
-
Ho RT, DeCaro M. Narrow QRS complex tachycardia with a high-frequency potential recorded near the His bundle: what is the mechanism? Heart Rhythm. 2005 Jun; 2(6):664-6.
-
Husser D, Binias KH, Stridh M, Sornmo L, Olsson SB, Molling J, Geller C, Klein HU, Bollmann A. Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram. Ann Noninvasive Electrocardiol. 2005 Apr; 10(2):206-10.
-
Husser D, Stridh M, Sornmo L, Geller C, Klein HU, Olsson SB, Bollmann A. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Am J Cardiol. 2005 Feb 15; 95(4):526-8.
-
Ramos E, O'leary ME. State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol. 2004 Oct 1; 560(Pt 1):37-49.
-
Bollmann A, Husser D, Stridh M, Soernmo L, Majic M, Klein HU, Olsson SB. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making. J Cardiovasc Electrophysiol. 2003 Oct; 14(10 Suppl):S154-61.
-
Kowey PR, Yan GX, Winkel E, Kao W. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches. Am J Cardiol. 2003 Mar 20; 91(6A):33D-38D.